311 Phase II trial of lymphodepletion plus adoptive cell transfer with or without dendritic cell vaccination in patients with metastatic melanoma

Similar Items

• Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma
  by: Sapna Patel, et al.
  Published: (2021-05-01)
• The efficacy of anti‐programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma
  by: Dai Ogata, et al.
  Published: (2021-04-01)
• Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
  by: Ronnie Shapira-Frommer, et al.
  Published: (2021-05-01)
• Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
  by: Carter M. Suryadevara, et al.
  Published: (2018-06-01)
• A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes
  by: Marie-Andrée Forget, et al.
  Published: (2017-08-01)